官方服务：
资源简介：
This study is designed to identify causative mutations conferring resistance to the PARP inhibitor Olaparib in mouse embryonic stem cells
应用场景：
创建时间：
2021-02-04
相关数据集
Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in Atopic Dermatitis
Dupilumab is a monoclonal antibody approved for the treatment of atopic dermatitis (AD); however, its effects on molecular, cellular, and immunological levels remain to be elucidated. In this study, b
NIAID Data Ecosystem60
Impact of ALK inhibition or phospho-deficient mutation of CDK9 on gene expression in ovarian cancer cells
The goal of this study is to determine the impact of ALK inhibition or phospho-deficient mutation of CDK9 on gene expresion profiles in ovarian cancer cells We performed bulk RNA sequencing on three c
NIAID Data Ecosystem50
Creation of a novel patient-derived xenograft and cell-line model for malignant phyllodes tumor, accompanied by characterization of effects of pazopanib therapy and its underlying mechanisms.
Malignant Phyllodes tumors (PT) are rare aggressive fibroepithelial neoplasms with high metastatic potential and lack effective therapy. We established a patient-derived xenograft (PDX) and cell-line
NIAID Data Ecosystem40
Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
Genomic amplification of 19q12 occurs in several cancer types including ovarian cancer where it is associated with primary treatment failure. We systematically attenuated expression of genes within th
NIAID Data Ecosystem50
Additional file 7 of MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC
Supplementary Material 7
NIAID Data Ecosystem40
